Elwood N J, Green A R, Melder A, Begley C G, Nicola N
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Leukemia. 1994 Jan;8(1):106-14.
SCL protein production was examined in a variety of hemopoietic cell lines by immunoblotting using specific polyclonal antisera. SCL protein was detected in erythroid, megakaryocyte, mast and early myeloid cell lines, as well as in several lymphoid leukemia cell lines which are known to harbor SCL gene rearrangements. In most cell lines, proteins of molecular weight 49 and 44 kDa were found, however two myeloid cell lines expressed only lower molecular weight species of 24 and 22 kDa. This size discrepancy appeared to be due to cell-specific translational regulation, since overexpression of a retrovirally transfected SCL gene yielded the higher molecular weight forms in most cell lines (GP+E-86, AT2.5, M1) but only the 22 kDa form in the myeloid cell line, WEHI-3B/D+. Overexpression of full-length SCL protein in the lymphoid cell lines, SupT1 and Raji, did not alter cell phenotype and there was no evidence for autoregulation of SCL transcription. The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously. In addition, the present results indicate that SCL protein size was determined by regulation of translation in a cell-specific manner.
使用特异性多克隆抗血清通过免疫印迹法检测了多种造血细胞系中的SCL蛋白产生情况。在红系、巨核细胞、肥大细胞和早期髓系细胞系中检测到了SCL蛋白,在一些已知存在SCL基因重排的淋巴白血病细胞系中也检测到了该蛋白。在大多数细胞系中,发现了分子量为49 kDa和44 kDa的蛋白质,然而,两个髓系细胞系仅表达分子量较低的24 kDa和22 kDa的蛋白质。这种大小差异似乎是由于细胞特异性翻译调控所致,因为逆转录病毒转染的SCL基因的过表达在大多数细胞系(GP+E-86、AT2.5、M1)中产生了较高分子量的形式,但在髓系细胞系WEHI-3B/D+中仅产生了22 kDa的形式。在淋巴细胞系SupT1和Raji中全长SCL蛋白的过表达并未改变细胞表型,也没有证据表明SCL转录存在自动调节。SCL蛋白合成的受限模式与先前记录的SCL mRNA的受限表达一致。此外,目前的结果表明,SCL蛋白大小是以细胞特异性方式通过翻译调控来确定的。